ESR1 and neoplasm: The general objective of this study was to evaluate the frequency and clinical value of the ESR1 and PIK3CA mutations identified in cfDNA and to compare these results with primary tumor samples to evaluate if the mutation was originally present in the tumor or if it occurred during metastasis.